Wells Fargo & Company Aptorum Group LTD Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Shares
4 transactions
Others Institutions Holding APM
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About Aptorum Group Ltd
- Ticker APM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,265,500
- Market Cap $16.3M
- Description
- Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...